Search
You have executed a tag search on The Deal Pipeline. Below, you will find a comprehensive list of stories tagged "Food and Drug Administration."
9 result(s) displayed (13 - 21 of 21)
The buyout firms sell Fougera to Novartis for $1.53 billion after spinning the U.S. business off from Nycomed when they sold the larger company to Takeda last year. Continue reading
Posted on May 3, 2012 2:11 PM
Discussions with potential bidders are at a preliminary stage, says the Irish drugmaker, which is 30.6% owned by THL, Bain Capital and CCMP Capital Advisors Continue reading
Posted on April 30, 2012 3:15 PM
Anything is possible, but after four wearying decades of the cancer wars, one remains skeptical of transformational progress. Evolution, after all, may be very slow. Continue reading
Posted on March 20, 2012 11:53 AM
The failure to get regulatory approval for its lead product in development and a slumping stock price has led the maker of a drug designed to prevent premature births to assess its strategic options, including a sale. Continue reading
Posted on March 15, 2012 2:23 PM
The price for electronic drug tester e-Screen could be as high as $340 million Continue reading
Posted on February 28, 2012 4:56 PM
The pharma strikes a solid deal for what could be a revolutionary cancer drug. Continue reading
Posted on January 20, 2012 12:00 PM
A clear way to manage reform is to invest alongside the broader forces that are emerging to bend the healthcare cost curve Continue reading
Posted on December 13, 2011 3:15 PM
In 2011, risk sharing returned to dealmaking in the sector as overconfidence left the market. Continue reading
Posted on December 9, 2011 12:00 PM
The venture capital firm cites regulatory uncertainty and high capital requirements as it turns its focus on technology companies Continue reading
Posted on November 8, 2011 2:13 PM
Movable Type search results powered by Fast Search
Ken deRegt will retire as head of fixed income at Morgan Stanley and be replaced by Michael Heaney and Robert Rooney. For other updates launch today's Movers & shakers slideshow.
Apax Partners offers $1.1 billion for Rue21, the same teenage fashion chain it took public in 2009. More video
